Vascular Disease and Surgery

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Articles

GRACE Risk Score Validation

Published:

13 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e12.

Lipoprotein(a) and Cardiovascular Disease

Published:

13 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e11.

P2Y12 Inhibitors for Special Populations in the Asia-Pacific Region

Published:

08 November 2021

Citation:

European Cardiology Review 2021;16:e43.

Developments in Total Arterial Myocardial Revascularisation

Citation:

Asia-Pacific Cardiology 2007;1(1):62-4